Global Carrier Screening Tests Market Growth (Status and Outlook) 2024-2030

Global Carrier Screening Tests Market Growth (Status and Outlook) 2024-2030

Carrier screening tests are genetic tests used to determine if an individual carries one or more mutations in their genes that could be passed on to their offspring. These mutations can cause genetic disorders, even if the carrier does not exhibit symptoms themselves.

Carrier screening can provide valuable information, helping individuals and couples make informed decisions about their reproductive options.

The global Carrier Screening Tests market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Carrier Screening Tests Industry Forecast” looks at past sales and reviews total world Carrier Screening Tests sales in 2022, providing a comprehensive analysis by region and market sector of projected Carrier Screening Tests sales for 2023 through 2029. With Carrier Screening Tests sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Carrier Screening Tests industry.

This Insight Report provides a comprehensive analysis of the global Carrier Screening Tests landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Carrier Screening Tests portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Carrier Screening Tests market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Carrier Screening Tests and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Carrier Screening Tests.

United States market for Carrier Screening Tests is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Carrier Screening Tests is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Carrier Screening Tests is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Carrier Screening Tests players cover Thermo Fisher Scientific, Eurofins Scientific, Illumina, Invitae, MedGenome, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Carrier Screening Tests market by product type, application, key players and key regions and countries.

Segmentation by Type:
NGS
Whole Exome Sequencing
Others

Segmentation by Application:
Couple
Individual

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
NGS
Whole Exome Sequencing
Others

Segmentation by Application:
Couple
Individual

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Eurofins Scientific
Illumina
Invitae
MedGenome
Myriad Genetics
Roche
Natera
OPKO Health
23andMe
bioMérieux
EKF Diagnostics
Gene by Gene (myDNA)
Fulgent Genetics
NxGen MDx
Sonic Genetics
My Baby
AncestryDNA
DiaSorin
Grifols
BGI Genomics
Chigene
Jiajian Medical Testing
Genesky
Berry Genomics
Weihansi Biomedical Technology
Annaroad

Please note: The report will take approximately 2 business days to prepare and deliver.